<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Infectious and Tropical Diseases</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0558A3C1-DACB-4CF7-8499-629C2EE516BA"><gtr:id>0558A3C1-DACB-4CF7-8499-629C2EE516BA</gtr:id><gtr:firstName>Ulrich</gtr:firstName><gtr:otherNames>Emil</gtr:otherNames><gtr:surname>Schaible</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700163"><gtr:id>A7676A84-1848-42C1-A557-96058BB38F25</gtr:id><gtr:title>The role of interleukin 18 for innate and acquired immunity in tuberculosis.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700163</gtr:grantReference><gtr:abstractText>The tuberculosis agent, Mycobacterium tuberculosis, kills 2 million people worldwide each year. Mycobacteria survive and proliferate within phagocytic cells of the immune system, the macrophages, defence cells with potent antibacterial mechanisms. Immune mediators such as interferon gamma (IFN-?) activate macrophages and promote bacterial killing. IFN-? is secreted by T lymphocytes and natural killer cells upon instruction by the macrophage-derived mediators, interleukin 12 and 18 (IL-18). We recently observed that mice lacking IL-18, die much earlier of experimental tuberculosis than wild type mice. Thus, IL-18 appears to be essentially involved in promoting protective immunity against tuberculosis. Here we propose to carry out a detailed analysis of the function of IL-18 during the immune responses against tubercle bacilli in order to understand its effect on downstream immune mediators promoting protective immunity. This knowledge will guide the development of improved immune prophylactic and therapeutic measures to boost protection against tuberculosis. Our research will be published in scientific journals widely accessible to the public.</gtr:abstractText><gtr:technicalSummary>Despite more than 100 years of research, tuberculosis is still the most important bacterial infection world wide. The causative agent, M. tuberculosis survives and proliferates within macrophages. Immune mediators such as interferon gamma (IFN-?) activate macrophages and promote bacterial killing. IFN-? is predominantly secreted by natural killer and T cells upon instruction by two cytokines, interleukin (IL) 12 and 18 primarily produced by dendritic cells and macrophages. IL-18 is involved in many immune functions. We recently found that mice lacking IL-18 succumbed to tuberculosis much earlier than wild type mice and presented with significantly higher bacterial numbers in the organs. Therefore, IL-18 appears to be essential in promoting protective immunity against tuberculosis. Yet, it remains unclear whether IL-18 boosts either innate or acquired immune elements or both to achieve protection. Here we propose to analyse in detail the function of IL-18 in immunity against tuberculosis in the mouse in order to understand the basis for protective immunity in tuberculosis, which is essential to improve prophylactic and therapeutic immune measures against this important disease.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>537054</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Immunology and Infection</gtr:department><gtr:description>The lung transcriptome in TB</gtr:description><gtr:id>8986608F-D3C4-43B4-909D-691FC9D6A669</gtr:id><gtr:impact>Interesting data, no publication yet.</gtr:impact><gtr:outcomeId>ojQEUo2NRMV-1</gtr:outcomeId><gtr:partnerContribution>They will perform transcripto,e analyses on the lungs from our IL-18 KO mice vs. WT ones.</gtr:partnerContribution><gtr:piContribution>We provide the tissues from TB infected animals including IL-18 KO as well as BAL from these mice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wurzburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Myeloid precursors in lung TB</gtr:description><gtr:id>1953304B-0CF9-4E40-9CBB-8B2C55B3157E</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>D8xMCGMw47s-1</gtr:outcomeId><gtr:partnerContribution>Conceptual collaboration and common experimental studies</gtr:partnerContribution><gtr:piContribution>Mtb infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Local community</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>3D7427A7-45F6-4D52-85F9-0383B9B5F352</gtr:id><gtr:impact>Public talk to local aggregation.

Public interest in the tuberculosis problematic in general.</gtr:impact><gtr:outcomeId>156748E6A41</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Excellence Cluster Inflammation at Interfaces Project</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>German Research Foundation (DFG)</gtr:fundingOrg><gtr:id>EEC7C778-7E81-4029-B52B-4CECDCFC8D54</gtr:id><gtr:outcomeId>KzTxVt9vqot</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>574064F7-1790-47A1-AC8A-13360946CA3B</gtr:id><gtr:title>Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a72830ea0c2b656d2b69838ea5d4bae7"><gtr:id>a72830ea0c2b656d2b69838ea5d4bae7</gtr:id><gtr:otherNames>Herbst S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>C6BB3531_EC6BB3531_E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90F9A808-DA03-4829-9EC4-29AB0AAE508A</gtr:id><gtr:title>Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/523474263fad7ec6be2e63aec4847bbe"><gtr:id>523474263fad7ec6be2e63aec4847bbe</gtr:id><gtr:otherNames>H?lscher C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>C019676175D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC6C9EF0-AE69-49E3-88F0-65D8AA3662F1</gtr:id><gtr:title>Purification and proteomics of pathogen-modified vacuoles and membranes.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular and infection microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/348a014dfe743df53dc3742e24929589"><gtr:id>348a014dfe743df53dc3742e24929589</gtr:id><gtr:otherNames>Herweg JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2235-2988</gtr:issn><gtr:outcomeId>56e0a23827e2b9.72254982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A342290-276A-4E75-A1B9-A6E8B6A518A2</gtr:id><gtr:title>WASH-driven actin polymerization is required for efficient mycobacterial phagosome maturation arrest.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/490c8e799e97177b7047384ba05f082f"><gtr:id>490c8e799e97177b7047384ba05f082f</gtr:id><gtr:otherNames>Kolonko M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>pm_13769_29_24119059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DDC164B-A5D5-4C48-ABD9-DAB3CFD28263</gtr:id><gtr:title>A role for IL-18 in protective immunity against Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccd6a184b1dfbc33ee5632ee729fcfb0"><gtr:id>ccd6a184b1dfbc33ee5632ee729fcfb0</gtr:id><gtr:otherNames>Schneider BE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>KTpbMa5tzKZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34F51E63-6131-4AB8-BAC8-3B2FBEF5D356</gtr:id><gtr:title>IL-17A promotes macrophage effector mechanisms against Trypanosoma cruzi by trapping parasites in the endolysosomal compartment.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09aa40e9228576c68c7f838ff5517098"><gtr:id>09aa40e9228576c68c7f838ff5517098</gtr:id><gtr:otherNames>Erdmann H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>pm_13769_29_23182712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71B12B5C-9E29-4894-AED0-C410D7281B0B</gtr:id><gtr:title>Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e925ef3cd780f3dde98813f2727de7ad"><gtr:id>e925ef3cd780f3dde98813f2727de7ad</gtr:id><gtr:otherNames>Corleis B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>pm_13769_29_22405091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDF92EE2-ED97-46E1-AA69-29E02D11F576</gtr:id><gtr:title>Macrophage defense mechanisms against intracellular bacteria.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ab013663648103e1aa55dbcf6c547e"><gtr:id>59ab013663648103e1aa55dbcf6c547e</gtr:id><gtr:otherNames>Weiss G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>56e0a2389c5e89.82240727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>349CE7F8-37C1-48C3-A72C-6F035CA12FF8</gtr:id><gtr:title>Neutrophils in tuberculosis--first line of defence or booster of disease and targets for host-directed therapy?</gtr:title><gtr:parentPublicationTitle>Pathogens and disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81cfa6ec473395198fefedd5ea266699"><gtr:id>81cfa6ec473395198fefedd5ea266699</gtr:id><gtr:otherNames>Dallenga T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2049-632X</gtr:issn><gtr:outcomeId>56e0a236c799d5.76981624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1259B5D4-C9B0-41D8-A82A-BB3A0711642F</gtr:id><gtr:title>Infection of human neutrophils to study virulence properties of Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81cfa6ec473395198fefedd5ea266699"><gtr:id>81cfa6ec473395198fefedd5ea266699</gtr:id><gtr:otherNames>Dallenga T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>56e0a23875b361.80052086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C50AF62-7669-41DE-A89E-710AFA0A8814</gtr:id><gtr:title>Innate immunity in tuberculosis: myths and truth.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abe96d18db4c115538bcad17de733e28"><gtr:id>abe96d18db4c115538bcad17de733e28</gtr:id><gtr:otherNames>Korbel DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>27973989ACC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA37A7CE-FEA9-4912-8B89-E6E630C74BAD</gtr:id><gtr:title>Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad26fbd89ea5daeea59ffc7dd4eeb81a"><gtr:id>ad26fbd89ea5daeea59ffc7dd4eeb81a</gtr:id><gtr:otherNames>Mueller AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13769_29_23110184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE4E479A-6148-4F97-92FB-19A32F1F42EF</gtr:id><gtr:title>The granuloma in tuberculosis: dynamics of a host-pathogen collusion.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2678a56f7e0f991c1c3791a5043bb00"><gtr:id>e2678a56f7e0f991c1c3791a5043bb00</gtr:id><gtr:otherNames>Ehlers S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>pm_13769_29_23308075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41137D7F-3BA3-471D-B274-4390BAD8A769</gtr:id><gtr:title>The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/661f4af4bfc55eb2a9b206f9984f421b"><gtr:id>661f4af4bfc55eb2a9b206f9984f421b</gtr:id><gtr:otherNames>Weinhold M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13769_29_23805193</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700163</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>